PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma
Molecular biomarkers assisting risk-group assignment and subsequent treatment stratification are urgently needed for patients with squamous cell cancer of the head and neck region (HNSCC). Aberrant methylation...